{"id":"W3089050578","doi":"10.1016/j.annonc.2020.08.927","title":"668P Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Biotech; European Society for Medical Oncology; Daiichi Sankyo Company; Emerson Collective; Incyte; Daiichi Sankyo Europe; Sanofi; Exelixis; GlaxoSmithKline; Society for Immunotherapy of Cancer; Astellas Pharma Global Development; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Parker Institute for Cancer Immunotherapy; Gateway for Cancer Research; Astellas Foundation for Research on Metabolic Disorders; Amgen; Pfizer","keywords":"Medicine; Prostate cancer; Proportional hazards model; Internal medicine; Radium-223; Cohort; Oncology; Cancer; Retrospective cohort study; Urology; Surgery; Bone metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001465731,0.0002178792,0.0002587699,0.0003270183,0.0002763947,0.0004679336,0.0002327445,0.0004178442,0.002805189],"category_scores_gemma":[0.001085542,0.0001378538,0.0003166593,0.0007468053,0.0002310718,0.000272048,0.0002450443,0.0004601318,0.0003712152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001823967,"about_ca_system_score_gemma":0.0002698175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00147381,"about_ca_topic_score_gemma":0.002427293,"domain_scores_codex":[0.9998666,0.00002996788,0.00001271685,0.00002052813,0.00002977406,0.00004028203],"domain_scores_gemma":[0.9994591,0.0001056469,0.0002537128,0.00001981245,0.00003287402,0.000128962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002211679,0.00008372635,0.9842747,0.00002865424,0.000135703,0.0004535459,0.00005633587,0.0002506535,0.002825446,0.00006497348,0.000575757,0.009038867],"study_design_scores_gemma":[0.00003589803,0.0002114036,0.997787,0.000006625842,0.00008800031,0.0006643395,0.00007787998,0.0002566487,0.0002531975,0.0001167336,0.0004968961,0.000005349073],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970627,0.0008362869,0.00008114461,0.0002225474,0.00002595143,0.000006139968,0.0003948256,0.000006432655,0.001364078],"genre_scores_gemma":[0.9991731,0.0001206509,0.00005028955,0.00004182399,0.00002598268,0.000003376418,0.0002554901,0.000002947279,0.0003263937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002805189,"threshold_uncertainty_score":0.009384334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3090772894855692,"score_gpt":0.4777500778161739,"score_spread":0.1686727883306047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}